Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

(Image credit: ©Alernon77/AdobeStock) jCyte recently announced the dosing of the first patients enrolled in the JC02-88 study for the evaluation of famzeretcel (jCell; jCyte) for the treatment of retinitis pigmentosa (RP).1 Famzeretcel consists of allogeneic retinal progenitor cells (RPCs) administered…

Educational committee member Oluwatosin U. Smith, MD, highlights the 2025 Ophthalmology Times EyeCon® and Optometry Times EyeCon® conference, a multispecialty meeting for ophthalmologists and optometrists, highlighting program updates, collaborative learning opportunities, and evolving approaches in patient care. To learn more…

(Image Credit: AdobeStock/Vittaya_25) Boehringer Ingelheim and Palatin Technologies have entered into a global research collaboration and licensing agreement to develop a potential first-in-class melanocortin receptor-targeted treatment for patients with retinal diseases. Under the terms of the agreement, Palatin will receive…
RemeGen and Santen Enter into Exclusive Licensing Agreement for Ophthalmic Innovative Drug RC28-E in Greater China and Asian countries PR Newswire Source: Author: | Date: 2025-08-18 07:00:00 Source: Author: | Date: 2025-08-18 07:00:00
HCPLive Five – Ophthalmology Updates at ASRS 2025 HCPLive Source: Author: | Date: 2025-08-18 07:00:00 Source: Author: | Date: 2025-08-18 07:00:00
Jeff Pettey, MD, MBA, Named Chair of the Department of Ophthalmology and Visual Sciences at the University of Utah and CEO of the John A. Moran Eye Center University of Utah Health Source: Author: | Date: 2025-08-18 07:00:00 Source: Author: |…
Boehringer pens $327M pact with Palatin to develop new therapies for diabetic retinopathy Fierce Biotech Source: Author: | Date: 2025-08-18 07:00:00 Source: Author: | Date: 2025-08-18 07:00:00
Kiora CEO to Reveal Latest Retinal Disease Therapeutic Developments at Major Ophthalmology Conference Stock Titan Source: Author: | Date: 2025-08-07 07:00:00 Source: Author: | Date: 2025-08-07 07:00:00
Innovations in Ophthalmology University of Colorado Anschutz Medical Campus Source: Author: | Date: 2025-08-06 06:18:00 Source: Author: | Date: 2025-08-06 06:18:00
Rishi Singh, MD, Named MGB Chair of Ophthalmology Mass General Giving Source: Author: | Date: 2025-08-05 07:00:00 Source: Author: | Date: 2025-08-05 07:00:00